Effective Management of XLA Associated Enteropathy with Vedolizumab Monotherapy

Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, Ballas ZK, Bonilla FA, Ochs HD, Walter JE. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37(3):287–94. https://doi.org/10.1007/s10875-017-0374-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Battat R, Dulai PS, Jairath V, Vande Casteele N. A product review of vedolizumab in inflammatory bowel disease. Hum Vaccin Immunother. 2019;15(10):2482–90. https://doi.org/10.1080/21645515.2019.1591139.

Article  PubMed  PubMed Central  Google Scholar 

Khan F, Person H, Dekio F, Ogawa M, Ho HE, Dunkin D, Secord E, Cunningham-Rundles C, Ward SC. Crohn’s-like Enteritis in X-Linked agammaglobulinemia: a Case Series and systematic review. J Allergy Clin Immunol Pract. 2021;9(9):3466–78. https://doi.org/10.1016/j.jaip.2021.04.070.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Çekiç Şükrü, Özgür T, Karalı Y, Ozkan T, Kilic S. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient? Turk J Pediatr. 2019;61:937. https://doi.org/10.24953/turkjped.2019.06.016.

Article  PubMed  Google Scholar 

Deng F, Wang H, Wang X. Chronic diarrhea with Villous Blunting of the Small Intestine under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked agammaglobulinemia: a Case Series. J Asthma Allergy. 2023;16:997–1006. PMID: 37772267; PMCID: PMC10522781.

Article  PubMed  PubMed Central  Google Scholar 

Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol. 2001;108(6):1012-20. https://doi.org/10.1067/mai.2001.120133. PMID: 11742281.

Molina J, Casin I, Hausfater P, Giretti E, Welker Y, Decazes J, Garrait V, Lagrange P, Modaï J. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS. 1995;9(8):881-5. https://doi.org/10.1097/00002030-199508000-00008. PMID: 7576322.

Grammatikos A, Thomas M, Johnston S, Moghaddas F, Albur M, Yong P, Buckland M, Grigoriadou S, Whyte AF, Herwadkar A, Gompels M. Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: a UK national case-series and review of the literature. J Allergy Clin Immunol Pract. 2023;11(9):2948–e29544. Epub 2023 Jun 8. PMID: 37301434.

Article  PubMed  Google Scholar 

Kochar B, Pate V, Kappelman MD, Long MD, Ananthakrishnan AN, Chan AT, Sandler RS. Vedolizumab is Associated with a lower risk of Serious infections Than Anti-tumor necrosis factor agents in older adults. Clin Gastroenterol Hepatol. 2022;20(6):1299–e13055. Epub 2021 Sep 3. PMID: 34481954; PMCID: PMC8891388.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif